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Dear Editor,
Severe hemorrhage in children with immune thrombocy-
topenic purpura (ITP) is rare and occurs in 3% of
patients [1]. Intracranial hemorrhage (ICH), the most
feared bleeding complication, has an estimated incidence
of 0.1–0.5% [1–3]. Mortality rate of ICH is high and
varies from 24–57% [2–4]. We report a patient with acute
ITP who developed fatal ICH shortly after starting high-
dose methylprednisolone.
A 5-year-old girl with an unremarkable medical and
family history presented to her pediatrician with acute
onset of bruising and petechiae. Physical examination
revealed no other abnormalities. Blood pressure was 112/
60 mmHg. Laboratory studies showed an isolated
trombocytopenia of 1×10
9/L (Table 1). She was diag-
n o s e dw i t ha c u t eI T Pa n dm a n a g e dc o n s e r v a t i v e l y .F o u r
days after presentation, she developed large ecchymoses
and epistaxis causing anemia. Intravenous immunoglobu-
lins (IVIg; 0.8 g/kg once) and packed red cells were
administered (Fig. 1). Platelet count remained low (1×10
9/L)
and mucosal bleeding continued. The girl was referred to our
department for further management. We saw a pale,
tachycardic girl with multiple ecchymoses and active
mucosal bleeding from nose and mouth. Hemoglobin was
7.4 g/dL and platelet count 2×10
9/L. After a second gift of
IVIg, prednisone 2 mg/kg/day, an erythrocyte transfusion
and a large dose of platelets (ten donor units), platelet count
rose to 21×10
9/L, hemoglobin stabilized and the clinical
condition of our patient improved dramatically. However,
36 h later, profuse mucosal bleeding from nose and mouth
recurred at a platelet count of 1×10
9/L. We started high-dose
methylprednisolone (15 mg/kg) together with another plate-
let transfusion. Shortly after starting the methylprednisolone
infusion, she complained of severe headache and instantly
developed generalized seizures. Blood pressure at that
moment was elevated: 170/90 mmHg. Computed tomogra-
phy (CT) showed extensive bifrontal ICH. Unfortunately, our
patient died of progressive herniation caused by massive
cerebral edema, despite continuous platelet transfusions and
intensive care management. Autopsy was not performed.
The main reason for clinicians to treat children with
acute ITP and minor bleeding symptoms is to raise
platelet counts in order to prevent severe bleeding
complications and in particular ICH. The question is
whether treatment really prevents these bleeding compli-
cations. The majority of children with severe bleeding or
ICH described in literature developed these complica-
tions despite prior therapy [1–5] .W h yd os o m ep a t i e n t s
develop ICH despite therapy? Apart from known risk
factors like head trauma, use of non-steroidal anti-
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tion, and bleeding beyond petechiae and ecchymoses [2, 3],
there are some other possible explanations. Patients may
suffer from refractory ITP and remain severely thrombo-
cytopenic despite therapy, leaving them at risk for
bleeding complications [6]. However, there is also a
possibility of either causing or worsening ICH due to
adverse effects of drug therapy. In our patient, the
temporal relationship between starting methylprednisolone
and development of headache and ICH remains remark-
able. A sudden rise in blood pressure, a known adverse
effect of high-dose methylprednisolone, could have ini-
tiated or worsened ICH.
In conclusion, this report shows that treatment of ITP
cannot always prevent ICH and may even be involved in
initiating or worsening ICH.
Table 1 Results of laboratory studies in our patient
Diagnosis Day 4 Day 5 Day 6 Day 7 Day 8 Day 9 (1 h
after ICH)
Day 9 (5 h
after ICH)
Day 10 (at moment
of herniation)
Units
Hemoglobin 11.6 5.8 11.3 7.4 8.6 10.6 9.0 6.4 g/dL
Hematocrit 0.32 0.17 0.32 0.23 0.28 0.24 0.17 L/L
Platelets 1 1 1 2 21 1 3 129 16 ×10
9/L
Leukocytes 12.7 7.5 10.6 14.0 12.6 15.6 25.1 ×10
9/L
Neutrophils 8.9 5.4 5.3 ×10
9/L
Lymphocytes 2.8 1.9 3.9 ×10
9/L
Activated partial
thromboplastin
time (APTT)
29 29 24 s
Prothrombin time (PT) 12.7 14.4 <10 s
Coombs test Negative Negative
ICH Intracranial hemorrhage
platelet count and interventions
0
50
100
150
200
250
300
96 120 144 168 192 216 240 264
hours after diagnosis
p
l
a
t
e
l
e
t
 
c
o
u
n
t
 
(
x
1
0
 
9
/
L
)
i i
♦♦
• • •• • • •
♦
Fig. 1 Overview of platelet
counts and interventions in our
patient. i=IVIg; white bar =
prednisone 2 mg/kg/day; white
arrow = high-dose methylpred-
nisolone infusion; black circle =
platelet transfusion; black dia-
mond = erythrocyte transfusion.
Lightning flash = event: the first
one represents onset of ICH, the
second one brain herniation
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